Metabolic Surgery May Cut Risk for Cardiovascular Events, Death

MONDAY, Sept. 28, 2020 -- Metabolic surgery on patients with morbid obesity and pharmacologically treated hypertension is associated with lower risk for major adverse cardiovascular events (MACE) and all-cause mortality versus individuals with...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news